Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)

Disney Tops Estimates: Bloomberg West (Full Show 02/09)
02:30 - Full episode of "Bloomberg West." Guests: Walter Todd, chief investment officer at Greenwood Capital, Ryan Petersen, chief executive officer at Flexport, Steve Huffman, chief executive officer at Reddit, Gary Cohn, president and chief operations officer at Goldman Sachs, Lenny Alcivar, client strategy director at Targeted Victory, and Seth Sternberg, chief executive officer at Honor. (Source: Bloomberg)
  • Can Markets Weather a Perfect Storm of Volatility?
  • What Are the Biggest Economic and Market Concerns?
  • Carlyle's Profit Declines 57% on Slow Asset Sales